SUPNSupernus Pharmaceuticals, Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic

Current Price: $50.20 (-0.67% today)

Market Cap: $2.91B

P/E (TTM): -75.20

Forward P/E (FY1): 26.10

EPS Growth: 83.2%

Analyst Upside: 29.5%

Relative Strength (RS%): 49

-15.9% from 52-week high

Back to Scanner

SUPN

NASDAQRS 49Score 44

Supernus Pharmaceuticals, Inc.

HealthcareDrug Manufacturers - Specialty & Generic$2.91B3 setups passing
$50.20
-0.7% ($0.34)
-15.9% from 52W High
P/E (TTM)
-75.20
Fwd P/E
26.10
PEG
0.07
Analyst Upside
+29.5%
EPS Growth
83.2%
Gross Margin
85.5%
ROE
-3.7%
D/E
0.04
Div Yield
0.0%
Avg Volume
438.4K

Price Chart

Key Levels

SMA 200
$46.01
SMA 50
$51.08
Price
$50.20
52W High
$59.69
Target
$65.00

Setup Radar

3/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst